For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Fees, a boil that needs to be lanced
Fees, a boil that needs to be lanced

Why do we still charge vulnerable people for healthcare, asks Don Matheson
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
1. Croxson B, Smith J, Cumming J. Patient Fees as a Metaphor for so much more in New Zealand’s Primary Health Care System. Wellington: Health Services Research Centre; 2009.
2. Selak V, Rahiri J-L, Jackson R, et al. Acknowledging and acting on racism in the health sector in Aotearoa New Zealand. NZ Med J 2020;133,1521:7–13.
3. Evans DB, Etienne C. Health systems financing and the path to universal coverage. Bulletin of the World Health Organization 2010;88;402.
http://dx.doi.org/10.2471/BLT.10.078741
4. Barış E, Silverman R, Wang H, et al. Walking the Talk: Reimagining Primary Health Care After COVID-19. World Bank, Washington, DC: World Bank Group, 2022.
5. Matheson D, Reidy J, Keenan R. Bringing primary health and community care in from the cold in the New Zealand health reforms? Tracing reform recommendations to budgets and structures. J Prim Health Care 2022;14(3):194–196.
https://www.publish.csiro.au/HC/pdf/HC22077
6. Chepulis L, Mayo C, Morison B, et al. Metformin adherence in patients with type 2 diabetes and its association with glycated haemoglobin levels. J Prim Health Care 2020;12:318-326.